摘要
慢性阻塞性肺疾病归属于中医“肺胀”“咳喘”“喘证”范畴,发病病机以本虚标实为特点,疾病病程主要分为急性发作期和临床缓解期(稳定期),其中急性发作期多为实证,稳定期多为虚证。本文结合中医辨证治疗的原则、临床常见中医药在慢性阻塞性肺疾病中的应用分析及国内外研究结果,对临床常见清热药、补虚药、化痰止咳平喘药、活血化瘀药的应用规律进行总结,寻求中成药介入慢性阻塞性肺疾病治疗的最佳切入点,以缓解患者症状,减少急性发作次数,提高患者生活质量。
Chronic obstructive pulmonary disease(COPD)belongs to the category of"lung distention""cough and asthma"and"syndrome characterized by dyspnea"in traditional Chinese medicine(TCM),the pathogenesis is characterized by the deficiency of the original standard.The course of disease is mainly divided into acute attack stage and clinical remission stage(stable stage),in which the acute attack period is mostly empirical,and the stable period is mostly deficiency syndrome.Based on the principles of TCM syndrome differentiation and treatment,the application analysis of common clinical Chinese medicine in the course of COPD,and the results of experimental research at home and abroad,this paper summarizes the application rules of common clinical antipyretic drugs,tonic drugs,expectorant,cough and asthma relieving drugs,and blood activating and stasis removing drugs,to seek the best entry point for Chinese patent drugs to intervene in the treatment of COPD,in order to alleviate the symptoms of patients,reduce the number of acute attacks,improve the quality of life of patients.
作者
周秋彤
阎小燕
ZHOU Qiutong;YAN Xiaoyan(School of Chinese Medicine,Shandong University of Traditional Chinese Medicine,Jinan 250014,China;Affiliated Hospital of Shandong University of Traditional Chinese Medicine,Jinan 250011,China)
出处
《实用心脑肺血管病杂志》
2020年第11期114-119,共6页
Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
基金
中国宋庆龄基金会基金项目(2018MZFS-035)。
关键词
慢性阻塞性肺疾病
中成药
药理作用
应用规律
综述
Chronic obstructive pulmonary disease
Chinese patent drugs
Pharmacologic actions
Application rule
Review
